Angiosarcoma of the heart

Angiosarcoma is a rare type of soft tissue sarcoma. It is a type of vascular tumour. Vascular tumours develop from endothelial cells. These cells make up the walls of blood or lymphatic vessels Open a glossary item.

Most tumours that start in the heart are benign Open a glossary item. About 10 out of 100 (10%) are malignant Open a glossary item. Most commonly these are soft tissue sarcomas.

Causes

We don’t know what causes angiosarcoma of the heart. Some of these cancers have been linked to past radiotherapy treatment. But as it is such a rare cancer, it is difficult to find a common cause.

Symptoms

Symptoms can vary depending on where in the heart the cancer is. Many people don’t have any symptoms until the cancer has spread to other parts of the body (advanced disease).

Symptoms can include:

  • breathlessness Open a glossary item
  • chest pain
  • feeling like you want to faint or fainting
  • tiredness

When symptoms do happen, they can be similar to those caused by heart failure. They may include breathlessness, chest pain, or fluid on the lung (pleural effusion Open a glossary item).

Sometimes a small piece of the tumour can break off and form a small clump or clot that blocks a blood vessel Open a glossary item. This is called an embolism. If an embolism travels through the bloodstream, it can block a blood vessel near the heart, causing pain.

Embolisms can also travel to other parts of the body, such as the brain, causing a stroke Open a glossary item.

Tests

Your doctor will examine you. You might have one or more of these tests: 

  • an MRI scan Open a glossary item
  • an ultrasound to look at the valves and structure of the heart (an echocardiogram Open a glossary item)
  • an ECG (electrocardiogram Open a glossary item)

Treatment

The main treatment for angiosarcoma of the heart is surgery. Your surgeon aims to remove as much of the cancer as possible, with a border of healthy tissue (margin) around it. Having a border of healthy tissue without any cancer cells is important. It aims to lower the risk of angiosarcoma coming back in the same place. 

Unfortunately, it is not always possible to completely remove the cancer. It depends on the size of the sarcoma, and where it is in your heart. 

You might also have radiotherapy or chemotherapy as part of your treatment. 

If your sarcoma has spread 

Sadly, angiosarcoma of the heart often grows quickly. In most people diagnosed, the sarcoma has already spread to other parts of the body. The most common place for it to spread is the lungs. In this situation, surgery will not cure it.

The doctor may offer other treatment to try and control the disease and relieve any symptoms for a time.

Coping

Coping with a diagnosis of a rare cancer can be especially difficult. Knowing more about your sarcoma and its treatment can make it easier. It can help you to make decisions and cope with what happens.

Sarcoma UK has support and information for people affected by soft tissue and bone sarcoma.

The Rare Cancer Alliance offer support and information to people with rare cancers.

Talking to other people who have the same thing can also help.

Our discussion forum Cancer Chat is a place for anyone affected by cancer. You can share experiences, stories and information with other people who know what you are going through.

  • Devita, Hellman and Rosenberg's Cancer: Principles and Practice of Oncology (12th edition)
    VT Devita, TS Lawrence and SA Rosenberg
    Wolters Kluwer Health, 2023

  • Cardiac tumors prevalence and mortality: A systematic review and meta-analysis

    M Rahouma and others

    International Journal of Surgery, 2020 April; 76: 178-189

  • Cardiac Tumors: Diagnosis, Prognosis, and Treatment

    R Bussani and others

    Current Cardiology Reports 22, 169 (2020)

  • Angiosarcoma: clinical and imaging features from head to toe

    A Gaballah and others

    The British Journal of Radiology, 90(1075), 2017

  • Advances in Image-Guided radiation therapy for cardiac angiosarcoma: The role of PET-CT and MRI 

    K Elsayad and others 

    Oncology Research and Treatment 2017 Volume 104, Number 1, pages 290-294

Last reviewed: 
15 Aug 2024
Next review due: 
15 Aug 2027

Related links